XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XRTX XORTX Therapeutics Inc.

交易中 11-22 13:54:27 EST

1.21

-0.06

-4.72%

最高1.26	最低1.21	成交量9,552
今开1.26	昨收1.27	日振幅3.94%
总市值390.09万	流通市值357.40万	总股本322.36万
成交额1.17万	换手率0.32%	流通股本295.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":1.2101,"timestamp":1732301078277,"preClose":1.27,"halted":0,"volume":9552,"delay":0,"floatShares":2953500,"shares":3223600,"eps":-0.288564,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0599,"latestTime":"11-22 13:54:27 EST","open":1.26,"high":1.26,"low":1.21,"amount":11701.610736,"amplitude":0.03937,"askPrice":1.31,"askSize":100,"bidPrice":1.23,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.288564,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"adjPreClose":1.27,"volumeRatio":1.046689},"requestUrl":"/m/hq/s/XRTX","defaultTab":"news","newsList":[{"id":"2485514293","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485514293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485514293?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:54","pubTimestamp":1732290873,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时54分，Xortx Therapeutics Inc.股票出现波动，股价大幅下挫5.14%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112223543398e44310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112223543398e44310&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2484760916","title":"Xortx Therapeutics Inc.盘中异动 急速下跌6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484760916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484760916?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:31","pubTimestamp":1731951067,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时31分，Xortx Therapeutics Inc.股票出现异动，股价快速跳水6.81%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013107abccf984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013107abccf984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2481303104","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481303104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481303104?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:46","pubTimestamp":1731077191,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时46分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨6.21%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463198e417da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463198e417da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2481184496","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.90%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184496?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:02","pubTimestamp":1730991729,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时02分，Xortx Therapeutics Inc.股票出现异动，股价快速上涨6.90%。截至发稿，该股报1.55美元/股，成交量545股，换手率0.02%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230209971a51be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230209971a51be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","XRTX","BK4139"],"gpt_icon":0},{"id":"2480340582","title":"Xortx Therapeutics Inc.盘中异动 早盘急速下挫6.99%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480340582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480340582?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:59","pubTimestamp":1730732375,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时59分，Xortx Therapeutics Inc.股票出现波动，股价快速下跌6.99%。截至发稿，该股报1.33美元/股，成交量1002股，换手率0.03%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225935ab9ecba6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225935ab9ecba6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","XRTX"],"gpt_icon":0},{"id":"2477371543","title":"Xortx Therapeutics Inc.盘中异动 大幅上涨5.26%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477371543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477371543?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:32","pubTimestamp":1729603922,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时32分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升5.26%。截至发稿，该股报1.80美元/股，成交量1316股，换手率0.05%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222132029f56b990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222132029f56b990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","XRTX"],"gpt_icon":0},{"id":"2476212776","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅下挫5.99%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476212776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476212776?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171897,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Xortx Therapeutics Inc.股票出现波动，股价快速下跌5.99%。截至发稿，该股报2.04美元/股，成交量6957股，换手率0.24%，振幅0.46%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721313795afa7cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721313795afa7cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2474746364","title":"Xortx Therapeutics Inc.盘中异动 股价大跌8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746364?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:33","pubTimestamp":1728567211,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时33分，Xortx Therapeutics Inc.股票出现异动，股价急速下跌8.82%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021333198e3bb6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021333198e3bb6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XRTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2474406715","title":"Xortx Therapeutics Inc.盘中异动 下午盘股价大涨10.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474406715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474406715?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:32","pubTimestamp":1728408730,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时32分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨10.46%。截至发稿，该股报1.69美元/股，成交量1.2064万股，换手率0.42%，振幅3.92%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100901321098e3b39a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100901321098e3b39a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2472574379","title":"Xortx Therapeutics Inc.股价拉升11.10% 市值涨54.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472574379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472574379?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:50","pubTimestamp":1728049803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时50分，Xortx Therapeutics Inc.股票出现波动，股价大幅拉升11.10%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004215003958fb571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004215003958fb571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2471385321","title":"Xortx Therapeutics Inc.盘中异动 急速拉升7.73%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471385321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471385321?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:45","pubTimestamp":1727703906,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时45分，Xortx Therapeutics Inc.股票出现波动，股价快速上涨7.73%。截至发稿，该股报1.67美元/股，成交量493股，换手率0.02%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214506ab6727ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214506ab6727ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2470469984","title":"Xortx Therapeutics Inc.盘中异动 股价大涨5.18%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470469984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470469984?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:18","pubTimestamp":1727205492,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时18分，Xortx Therapeutics Inc.股票出现波动，股价快速拉升5.18%。截至发稿，该股报1.73美元/股，成交量2.7292万股，换手率0.94%，振幅8.23%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250318129719c710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250318129719c710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","XRTX"],"gpt_icon":0},{"id":"2468884570","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.20%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468884570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468884570?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752730,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升5.20%。截至发稿，该股报1.82美元/股，成交量1552股，换手率0.05%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213210956fa307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213210956fa307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","XRTX","BK4139"],"gpt_icon":0},{"id":"2465523700","title":"爱奇艺体育致歉！","url":"https://stock-news.laohu8.com/highlight/detail?id=2465523700","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465523700?lang=zh_cn&edition=full","pubTime":"2024-09-05 22:52","pubTimestamp":1725547936,"startTime":"0","endTime":"0","summary":"9月5日晚间，爱奇艺体育微博发文称，非常抱歉在今晚世预赛亚洲区18强赛中国男足首场客场对阵日本队的直播中，因球迷的热情，造成瞬时流量过大。我们的技术服务资源分配超出限额，给部分用户造成了不好的观赛体验。后续会进一步加强技术预案和运营能力，给大家提供更稳定可靠的直播服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409053176854230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0229945570.USD","HK0000320264.USD","89888","LU0831093199.SGD","BK1575","LU0326950275.SGD","BK1609","HK0000306701.USD","LU0456827905.SGD","BK4108","LU0823426308.USD","LU0708995583.HKD","LU0228367735.SGD","LU0588546209.SGD","LU0630378429.USD","LU1328615791.USD","LU0856984785.SGD","LU1048588211.SGD","LU0819121731.USD","LU0359202008.SGD","LU0821914370.USD","LU0823426480.USD","BK4526","LU0173614495.USD","BK1095","LU0320764599.SGD","LU0072462343.USD","LU2039709279.SGD","LU0762541174.USD","LU1115378108.SGD","LU0039217434.USD","LU0762542818.HKD","BK4531","LU0287142896.SGD","BK4552","SG9999002828.SGD","IE0034224299.USD","LU0043850808.USD","LU0417516902.SGD","LU2778985437.USD","XRTX","LU0307460666.USD","LU0762540952.USD","HK0000306685.HKD","LU0348825331.USD","BK1587","BK4505","LU0348735423.USD"],"gpt_icon":1},{"id":"2464406815","title":"估值150亿GPU独角兽，陷入困境","url":"https://stock-news.laohu8.com/highlight/detail?id=2464406815","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464406815?lang=zh_cn&edition=full","pubTime":"2024-09-03 10:12","pubTimestamp":1725329571,"startTime":"0","endTime":"0","summary":"国产GPU，有的已经启动IPO，有的已被迫停止前行。近日，据界面新闻消息，国产GPU公司象帝先计算技术（重庆）有限公司于8月30日召开全员会议，宣布公司遭遇资金危机，计划与员工终止劳动合同。象帝先管理层在全员会议上表示，象帝先与投资方签了一份B轮满5亿元的对赌协议，但最终未达成协议条款，所以被股东起诉。在今年4月份，象帝先还获得2024年度重庆市“独角兽企业”称号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/239407","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0079474960.USD","BK4573","IE0004445015.USD","LU1880398554.USD","BK4543","BK4581","IE00BKPKM429.USD","IE00BJLML261.HKD","LU2458330169.SGD","IE00BN29S564.USD","LU1316542783.SGD","IE0004445239.USD","IE0009356076.USD","LU1242518857.USD","IE00B1XK9C88.USD","IE00BYXW3230.USD","BK4587","BK4588","IE0034235303.USD","IE00B775H168.HKD","BK4585","BK4503","LU1803068979.SGD","LU1989764664.SGD","BK4575","IE00B3M56506.USD","IE00BJJMRX11.SGD","LU0061474960.USD","IE00BKDWB100.SGD","XRTX","IE00B5949003.HKD","BK4592","IE0034235188.USD","LU0081259029.USD","BK4527","BK4579","LU0057025933.USD","IE00BHPRN162.USD","LU0889565833.HKD","BK4529","LU0127658192.USD","GB00BDT5M118.USD","LU2458330243.SGD","IE00BDCRKT87.USD","IE0034235295.USD","LU2250418816.HKD","LU1923623000.USD","IE00B19Z8X17.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2464588868","title":"巴西最高法院分庭形成多数，支持暂停 X 议员资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2464588868","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464588868?lang=zh_cn&edition=full","pubTime":"2024-09-02 22:22","pubTimestamp":1725286923,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透巴西利亚9月2日 - 巴西最高法院五人合议庭周一形成多数，维持亚历山大-德-莫赖斯（Alexandre de Moraes）法官的裁决，以不符合当地规范为由关闭该国的社交媒体平台 X。弗拉维奥-迪诺（Flavio Dino）和克里斯蒂亚诺-扎宁（Cristiano Zanin）两位大法官支持莫赖斯的观点，即使路易斯-福克斯（Luiz Fux）和卡门-露西亚（Carmen Lucia）两位大法官尚未投票，也形成了多数派。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2213496289.HKD","LU2357305700.SGD","LU0316494557.USD","LU1720051108.HKD","LU0964807845.USD","LU1429558221.USD","LU1914381329.SGD","BK4527","LU1861215975.USD","LU1551013425.SGD","BK4555","LU2249611893.SGD","BK4099","IE00BJLML261.HKD","LU0348723411.USD","SG9999015986.USD","LU1548497426.USD","BK4533","BK4548","LU0082616367.USD","BK4574","LU1629891620.HKD","LU1861558580.USD","LU0234570918.USD","LU0820562030.AUD","LU0823414478.USD","IE00B1XK9C88.USD","BK4534","BK4511","LU1720051017.SGD","LU1852331112.SGD","LU0053666078.USD","BK4550","BK4581","IE00BWXC8680.SGD","LU1861220033.SGD","LU2023250330.USD","SG9999015952.SGD","BK4551","LU0823411888.USD","LU1551013342.USD","LU1861559042.SGD","IE00BSNM7G36.USD","SG9999015978.USD","XRTX","LU2756315664.SGD","LU0719512351.SGD","LU0943347566.SGD","LU0234572021.USD","LU1435385759.SGD"],"gpt_icon":1},{"id":"2460043020","title":"Xortx Therapeutics Inc.盘中异动 急速上涨5.14%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460043020","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460043020?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:45","pubTimestamp":1724161511,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时45分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升5.14%。截至发稿，该股报1.50美元/股，成交量720股，换手率0.02%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021451198e3586c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021451198e3586c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2459475870","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.12%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459475870","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459475870?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:17","pubTimestamp":1723731451,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时17分，Xortx Therapeutics Inc.股票出现异动，股价快速拉升5.12%。截至发稿，该股报1.54美元/股，成交量12股，换手率0.00%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522173197198d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522173197198d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2459189178","title":"Xortx Therapeutics Inc.盘中异动 股价大涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189178","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189178?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:54","pubTimestamp":1723564495,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时54分，Xortx Therapeutics Inc.股票出现波动，股价大幅拉升5.76%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235455aefea0f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235455aefea0f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","XRTX"],"gpt_icon":0},{"id":"2458344269","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.67%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458344269","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458344269?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:43","pubTimestamp":1723135384,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时43分，Xortx Therapeutics Inc.股票出现异动，股价快速拉升6.67%。截至发稿，该股报1.60美元/股，成交量705股，换手率0.02%，振幅3.33%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.38%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900430496825393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900430496825393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XRTX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.0964},{"period":"1month","weight":-0.1839},{"period":"3month","weight":-0.0102},{"period":"6month","weight":-0.5097},{"period":"1year","weight":-0.5097},{"period":"ytd","weight":-0.4524}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立，名称为ReVasCor Inc.在2018年1月10日，公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司，专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法，这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.16276},{"month":2,"riseRate":0.333333,"avgChangeRate":0.063564},{"month":3,"riseRate":0.666667,"avgChangeRate":0.130043},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.089007},{"month":5,"riseRate":0.666667,"avgChangeRate":0.012197},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.062719},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.024783},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059348},{"month":9,"riseRate":0,"avgChangeRate":-0.142465},{"month":10,"riseRate":0,"avgChangeRate":-0.308198},{"month":11,"riseRate":0.25,"avgChangeRate":-0.091185},{"month":12,"riseRate":0,"avgChangeRate":-0.081572}],"exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}